GlobeNews Wire

Virtual Humans Everywhere: iFLYTEK Brings AI Service into Real-World Scenarios at MWC26

Barcelona, March 05, 2026 (GLOBE NEWSWIRE) -- At MWC26, iFLYTEK presented a comprehensive lineup of virtual human technologies, drawing strong…

4 weeks ago

Oculis to Participate in Upcoming Investor Conferences

ZUG, Switzerland, March 05, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a…

4 weeks ago

Oculis Publishes 2025 Consolidated Financial Statements

ZUG, Switzerland, March 05, 2026 (GLOBE NEWSWIRE) -- Following the Company‘s press release published on March 3, the audited consolidated…

4 weeks ago

Press Release: Sanofis Board of Directors proposes the appointment of Christel Heydemann as an independent director

Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director  Paris, March 5, 2026. The Board of Directors of Sanofi has…

4 weeks ago

$HODL: Creator of Crypto’s Iconic 2013 “I AM HODLING” Post Verifies On-Chain Backing of Fair-Launched Solana Token via PumpSwap

Tokyo, Japan, March 04, 2026 (GLOBE NEWSWIRE) -- HODL, a newly fair-launched token on the Solana blockchain, has officially announced its…

4 weeks ago

Expedience Software Recognized as a Representative Vendor in the 2025 Gartner Market Guide for RFP Response Management Applications

MANCHESTER, N.H., March 04, 2026 (GLOBE NEWSWIRE) -- Expedience Software, a leading provider of proposal automation technology, today announced its…

4 weeks ago

iFLYTEK Debuts AI Glasses and New AI Devices at MWC26, Advancing AI for Use, AI for Trust

Barcelona, March 04, 2026 (GLOBE NEWSWIRE) -- iFLYTEK held a global launch event on March 3 during MWC26 in Barcelona,…

4 weeks ago

Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute

Study is Real-World Evaluation of the Clinical Utility of Sodium Thiosulfate Injection (PEDMARK®) in Reducing the Risk of Ototoxicity in Adolescent…

4 weeks ago

TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Presented positive updated data from the ALLOHA™ Phase 1 heme trial at 67th American Society of Hematology (ASH) Annual Meeting…

4 weeks ago

Kamada to Announce Fiscal Year and Fourth Quarter 2025 Financial Results on March 11, 2026

Company to Host Conference Call at 8:30am ET March 04, 2026 07:00 ET  | Source: Kamada Ltd. REHOVOT, Israel, and…

4 weeks ago